美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Korsana Biosciences Inc

31.40

-0.6800-2.12%

成交量：1.28萬

成交額：41.04萬

市值：14.29億

市盈率：-2.67

高：32.05

開：32.00

低：31.40

收：32.08

52周最高：59.36

52周最低：7.19

股本：4,550.00萬

流通股本：4,504.23萬

量比：0.87

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-11.7644

每股收益(LYR):-7.7700

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-4.04

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Korsana Biosciences Inc

交易所：

NASDAQ

成立時間：

2024

員工人數：

- -

公司地址：

221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States

官網：

http://www.korsana.com

郵編：

02453

電話：

傳真：

- -

簡介：

Korsana Biosciences, Inc.於2018年9月6日在馬薩諸塞州聯邦註冊成立。Korsana Biosciences的成立是為了減輕患者和護理人員的神經退行性疾病負擔。與Paragon Therapeutics合作開發的Therapeutic Targeting是一種新型的血腦屏障穿透式穿梭平台，旨在實現大腦內部顯著更高的藥物濃度，並克服早期穿梭技術的限制。Korsana正在推進一系列針對神經退行性疾病的創新THETA療法，首先是用於治療阿爾茨海默病的KRSA-028。

董事

名稱

職位

Jonathan Violin

Chief Executive Officer and Director and President

Andrew Gottesdiener

Director

Heidi Henson

Director

Michelle Pernice

Director

Nimish Shah

Director

Tomas Kiselak

Director

股東

名稱

職位

Jonathan Violin

Chief Executive Officer and Director and President

Mark Vignola

Chief Financial Officer

Madelyn Zeylikman

General Counsel and Secretary

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/KRSA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","market":"US","secType":"STK","nameCN":"Korsana Biosciences Inc","latestPrice":31.4,"timestamp":1789570121909,"preClose":32.08,"halted":0,"volume":12827,"delay":0,"changeRate":-0.02119700748129675,"floatShares":45042270,"shares":45500000,"eps":-11.7644,"marketStatus":"交易中","change":-0.68,"latestTime":"09-16 10:52:13 EDT","open":31.9999,"high":32.045,"low":31.4,"amount":410351.63548,"amplitude":0.020106,"askPrice":32.15,"askSize":9,"bidPrice":31.4,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-11.7644,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":32.08,"preHourTrading":{"tag":"盘前","latestPrice":32.08,"preClose":32.08,"latestTime":"04:00 EDT","volume":5,"amount":160.39999999999998,"timestamp":1789545607803,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":32.08,"latestTime":"19:56 EDT","volume":32,"amount":1004.825,"timestamp":1789516570449,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.86968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","floatShares":45042270,"roa":"--","roe":"--","lyrEps":-7.77,"volumeRatio":0.86968,"shares":45500000,"dividePrice":0,"high":32.045,"amplitude":0.020106,"preClose":32.08,"low":31.4,"week52Low":7.1862,"pbRate":"--","week52High":59.36,"institutionHeld":0,"latestPrice":31.4,"committee":0.834862,"eps":-11.7644,"divideRate":0,"volume":12827,"delay":0,"ttmEps":-11.7644,"open":31.9999,"prevYearClose":8.89,"prevWeekClose":31.905,"prevMonthClose":25.76,"prevQuarterClose":23.73,"fiveDayClose":26.2,"twentyDayClose":28.84,"sixtyDayClose":22.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-09","symbol":"KRSA","defaultRemindTime":1788960600000,"type":"split","dateTimestamp":1788926400000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRSA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1789444800000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1966002000,"yearFounded":2024,"address":"221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"(781) 516-2325"},"stockCompanyDetail":{"websiteUrl":"http://www.korsana.com","stockEarnings":[{"period":"1week","weight":0.3639},{"period":"1month","weight":0.2092},{"period":"3month","weight":0.4412},{"period":"6month","weight":2.035},{"period":"1year","weight":0.9419},{"period":"ytd","weight":2.6085}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Korsana Biosciences, Inc.於2018年9月6日在馬薩諸塞州聯邦註冊成立。Korsana Biosciences的成立是為了減輕患者和護理人員的神經退行性疾病負擔。與Paragon Therapeutics合作開發的Therapeutic Targeting是一種新型的血腦屏障穿透式穿梭平台，旨在實現大腦內部顯著更高的藥物濃度，並克服早期穿梭技術的限制。Korsana正在推進一系列針對神經退行性疾病的創新THETA療法，首先是用於治療阿爾茨海默病的KRSA-028。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.030269},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.005726},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.111354},{"month":4,"riseRate":0.428571,"avgChangeRate":0.134458},{"month":5,"riseRate":0.25,"avgChangeRate":-0.02829},{"month":6,"riseRate":0.5,"avgChangeRate":0.038893},{"month":7,"riseRate":0.375,"avgChangeRate":0.026358},{"month":8,"riseRate":0.625,"avgChangeRate":0.100342},{"month":9,"riseRate":0.375,"avgChangeRate":0.012567},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.324291},{"month":11,"riseRate":0.285714,"avgChangeRate":0.0186},{"month":12,"riseRate":0.428571,"avgChangeRate":0.106805}],"exchange":"NASDAQ","name":"Korsana Biosciences Inc","nameEN":"Korsana Biosciences Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":{"directors":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Andrew Gottesdiener","position":"Director"},{"name":"Heidi Henson","position":"Director"},{"name":"Michelle Pernice","position":"Director"},{"name":"Nimish Shah","position":"Director"},{"name":"Tomas Kiselak","position":"Director"}],"executives":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Mark Vignola","position":"Chief Financial Officer"},{"name":"Madelyn Zeylikman","position":"General Counsel and Secretary"}]}}}